Spotlight intensifies on cancer drug reimbursement

Pharmaceutical manufacturers have long been under scrutiny for the methodsthey employ in marketing their products to physicians. Now, increasing concernthat drug makers are winning physician favor by deeply discounting chemotherapymedicines is placing those physicians under the microscopes of federal andstate authorities.

Related Videos

Related Content

Advertisement

October 10th 2024

How to code for cystoscopy with litholapaxy of more than 40 bladder calculi

Jonathan Rubenstein, MD Mark Painter

"If the documentation supported the use of modifier –22, it should be appended," write Jonathan Rubenstein, MD, and Mark Painter.

March 21st 2024

Health policy in urology: 2024 AUA Advocacy Summit recap

Urology Times staff

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.

September 27th 2024

UroCuff coding presents a “conundrum” for billers

Jonathan Rubenstein, MD Mark Painter

"When determining which code you should use, you must consider your Medicare carrier’s published rules and commercial payer processing policies," write Jonathan Rubenstein, MD, and Mark Painter.

August 28th 2023

How APPs can bridge the gap in urologist shortages

Urology Times staff

In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.

August 23rd 2024

Money Matters: Using donor-advised funds to avoid paying capital gains taxes

Jeff Witz, CFP

"Donor-advised funds are a fast-growing charitable giving vehicle in the US because they are one of the easiest and most tax-advantageous ways to give to charity," writes Jeff Witz, CFP.

August 20th 2024

Renting or buying: Which is the better option for physicians?

Jeff Witz, CFP

"Early-career physicians should ask themselves whether they really need to purchase a home right away or whether they would be better served renting for a few years," writes Jeff Witz, CFP.

Related Content

Advertisement

October 10th 2024

How to code for cystoscopy with litholapaxy of more than 40 bladder calculi

Jonathan Rubenstein, MD Mark Painter

"If the documentation supported the use of modifier –22, it should be appended," write Jonathan Rubenstein, MD, and Mark Painter.

March 21st 2024

Health policy in urology: 2024 AUA Advocacy Summit recap

Urology Times staff

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.

September 27th 2024

UroCuff coding presents a “conundrum” for billers

Jonathan Rubenstein, MD Mark Painter

"When determining which code you should use, you must consider your Medicare carrier’s published rules and commercial payer processing policies," write Jonathan Rubenstein, MD, and Mark Painter.

August 28th 2023

How APPs can bridge the gap in urologist shortages

Urology Times staff

In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.

August 23rd 2024

Money Matters: Using donor-advised funds to avoid paying capital gains taxes

Jeff Witz, CFP

"Donor-advised funds are a fast-growing charitable giving vehicle in the US because they are one of the easiest and most tax-advantageous ways to give to charity," writes Jeff Witz, CFP.

August 20th 2024

Renting or buying: Which is the better option for physicians?

Jeff Witz, CFP

"Early-career physicians should ask themselves whether they really need to purchase a home right away or whether they would be better served renting for a few years," writes Jeff Witz, CFP.